miR-212-3p was a novel miRNA found aberrantly expressed in LPS-induced RAW264.7 cells. HMGB1 was revealed to be a totally new target of miR-212-3p in LPS-stimulated inflammatory response. p38 MAPK and ERK signaling pathways can be inhibited by miR-212-3p through targeting HMGB1.